When we examined each cancer separately, total serum levels were significantly higher in lung cancer cases (TGF-β1: median 22.8 ng/mL, vs. 19.4 in controls; VEGF: median 277 pg/mL, vs. 186 in controls; Table2). This evidence concerns the gene VEGFA and lung carcinoma.